Using PET ¹⁸F-FDG, ¹¹CO, and ¹⁵O-water for monitoring prostate cancer during a phase II anti-angiogenic drug trial with thalidomide

K. A. Kurdziel, S. L. Bacharach, J. A. Carrasquillo, S. Huebsch, M. Whatley, D. Sellers, S. Steinberg, S. K. Libutti, J. Pluda, E. Reed, W. Dahut, W. D. Figg

Research output: Contribution to journal › Article › peer-review